KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Debt to Equity (2020 - 2025)

Fulgent Genetics (FLGT) has disclosed Debt to Equity for 6 consecutive years, with $0.03 as the latest value for Q4 2025.

  • Quarterly Debt to Equity rose 2.03% to $0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.03 through Dec 2025, up 2.03% year-over-year, with the annual reading at $0.03 for FY2025, 2.03% up from the prior year.
  • Debt to Equity hit $0.03 in Q4 2025 for Fulgent Genetics, roughly flat from $0.03 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.03 in Q3 2025 to a low of $0.01 in Q2 2021.
  • Historically, Debt to Equity has averaged $0.02 across 5 years, with a median of $0.02 in 2021.
  • Biggest five-year swings in Debt to Equity: surged 3895.97% in 2021 and later crashed 41.93% in 2022.
  • Year by year, Debt to Equity stood at $0.01 in 2021, then grew by 11.43% to $0.01 in 2022, then soared by 56.54% to $0.02 in 2023, then increased by 17.73% to $0.03 in 2024, then increased by 2.03% to $0.03 in 2025.
  • Business Quant data shows Debt to Equity for FLGT at $0.03 in Q4 2025, $0.03 in Q3 2025, and $0.03 in Q2 2025.